1. Intravitreal bevacizumab injections for central serous chorioretinopathy show long-term outcomes of complete remission in 90% of patients,
2. Thick choroids and serous retinal detachment at baseline were risk factors for recurrence.
Evidence Rating Level: 2 (Good)
Central serous chorioretinopathy (CSC) is an ocular disease characterized by retinal detachment due to the...